DarioHealth Corp. Liabilities, Fair Value Adjustment
DarioHealth Corp. (DRIO) reported Liabilities, Fair Value Adjustment of -$3.84 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:LiabilitiesFairValueAdjustment · last filed 2026-08-11
- DarioHealth Corp. liabilities, fair value adjustment for the quarter ending 2025-12-31 was $0.00.
- DarioHealth Corp. liabilities, fair value adjustment for the quarter ending 2025-09-30 was $766.00K.
- DarioHealth Corp. liabilities, fair value adjustment for the quarter ending 2025-06-30 was -$3.40M.
- DarioHealth Corp. liabilities, fair value adjustment for the quarter ending 2025-03-31 was -$1.21M.
- DarioHealth Corp. liabilities, fair value adjustment for fiscal 2025 was -$3.84M.
- DarioHealth Corp. liabilities, fair value adjustment for fiscal 2024 was -$4.30M.
- DarioHealth Corp. liabilities, fair value adjustment for fiscal 2023 was -$4.89M, a 226.85% decline from fiscal 2022.
- DarioHealth Corp. liabilities, fair value adjustment for fiscal 2022 was $3.86M.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 3 month as first filed | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month | Liabilities, Fair Value Adjustment 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $766.00K derived: sum of 2 quarters · filed 2026-03-19 | -$2.63M derived: sum of 3 quarters · filed 2026-08-11 | -$3.84M 10-K · filed 2026-03-19 | ||
| 2025-09-30 | $766.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.63M derived: sum of 2 quarters · filed 2026-08-11 | -$3.84M 10-Q · filed 2025-11-13 | -$4.87M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | -$3.40M 10-Q · filed 2026-08-11 | -$4.61M 10-Q · filed 2026-08-11 | -$5.63M derived: sum of 3 quarters · filed 2026-08-11 | -$6.86M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | -$1.21M 10-Q · filed 2026-05-13 | -$2.23M derived: sum of 2 quarters · filed 2026-05-13 | -$3.45M derived: sum of 3 quarters · filed 2026-05-13 | -$4.61M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$2.25M derived: sum of 2 quarters · filed 2026-03-19 | -$3.40M derived: sum of 3 quarters · filed 2026-03-19 | -$4.30M 10-K · filed 2026-03-19 | ||
| 2024-09-30 | -$1.22M 10-Q · filed 2025-11-13 | -$2.38M derived: sum of 2 quarters · filed 2025-11-13 | -$3.28M 10-Q · filed 2025-11-13 | -$3.82M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$1.15M 10-Q · filed 2025-08-12 | -$2.06M 10-Q · filed 2025-08-12 | -$2.60M derived: sum of 3 quarters · filed 2025-08-12 | -$3.50M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$904.00K 10-Q · filed 2025-05-14 | -$1.44M derived: sum of 2 quarters · filed 2025-05-14 | -$2.34M derived: sum of 3 quarters · filed 2025-05-14 | -$4.94M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$1.44M derived: sum of 2 quarters · filed 2025-03-10 | -$4.03M derived: sum of 3 quarters · filed 2025-03-10 | -$4.89M 10-K · filed 2025-03-10 | $4.89M 10-K · filed 2024-03-28 | |
| 2023-09-30 | -$898.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$3.49M derived: sum of 2 quarters · filed 2024-11-07 | -$4.35M 10-Q · filed 2024-11-07 | $1.45M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.46M 10-Q · filed 2024-08-08 | $2.35M derived: sum of 3 quarters · filed 2024-08-08 | $574.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$861.00K 10-Q · filed 2024-05-15 | $211.00K 10-Q · filed 2023-05-11 | $4.94M derived: sum of 2 quarters · filed 2024-05-15 | $3.17M derived: sum of 3 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $4.03M derived: sum of 2 quarters · filed 2024-03-28 | $3.86M 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.95M 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | -$172.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |